Related Experiment Video
Updated: Jan 17, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Choice of Hormone Assay to Monitor Feminizing Gender-Affirming Hormone Therapy
Daniel J Slack1, Nithya Krishnamurthy2, Meghan Garrity2
1Division of Endocrinology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Center for Transgender Medicine and Surgery, Mount Sinai Health System, New York, New York.
Objective:
Studies have shown variability in the correlation among testosterone (T) concentrations, estradiol (E2) concentrations, and other clinical parameters to monitor response to feminizing gender-affirming hormone therapy (GAHT). We aimed to determine the degree to which data support the use of serum T, serum E2, luteinizing hormone (LH), or follicle stimulating hormone to monitor feminizing GAHT with the goal of decreasing the effect of endogenous androgens.
Methods:
We conducted a cross-sectional analysis of T and E2 concentrations in 9916 transfeminine individuals prescribed estradiol to examine the association between individuals' most recent serum T, E2, LH, and follicle stimulating hormone concentrations in the context of feminizing GAHT treatment.
Results:
Changes in T concentrations were inversely correlated with changes in E2 concentrations (P < .001). However, orchiectomy, age, and the use of spironolactone were associated with changes in T, but not E2 concentrations (P < .001). Changes in T concentrations were also correlated with changes in LH (P < .05). Such correlations were not demonstrated with E2 concentrations.
Conclusions:
To monitor feminizing GAHT, it may be reasonable to favor target T concentrations over E2 concentrations in patients with testes and to consider LH concentrations in patients without testes who are not taking gonadotropin-releasing hormone agonists.
Related Concept Videos
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Therapeutic Drug Monitoring: Drug Analysis Methods
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Testosterone: Functions and Regulation

